Biogen Idec has already primed expectations with remarks on promising results seen in early-stage results for its Alzheimer’s drug BIIB037, so tomorrow’s big reveal has focused a bright beam of attention on the company.

…read more

Source: Analysts spread the love as Biogen Idec excites on MS, Alzheimer’s


0 No comments